BioDlink International Co., Ltd. is clinical stage biopharmaceutical company, which engages in developing and commercializing oncology drugs and therapies. The company is headquartered in Suzhou, Jiangsu and currently employs 604 full-time employees. The company went IPO on 2019-11-08. The firm and its subsidiaries are primarily engaged in research, development, manufacturing, and marketing of anti-tumor drugs, contract development and manufacturing organization (CDMO) business and license-out of self-developed biological drugs in the People’s Republic of China. The firm owns a pipeline of oncology drug candidates, which include monoclonal antibodies (mAbs) and antibody-drug conjugates (ADCs). The firm has built and established a fully integrated in-house platform of discovery, process development, quality management, pre-clinical and clinical development, as well as commercial-scale manufacturing facilities and sales and marketing capabilities. The firm mainly conducts its businesses in the domestic market.
01875.HK stock price ended at $4.2 on 목요일, after rising 0.00%
On the latest trading day Feb 12, 2026, the stock price of 01875.HK rose by 0.00%, climbing from $4.26 to $4.20. During the session, the stock saw a volatility of 4.07%, with prices oscillating between a daily low of $4.18 and a high of $4.35. Notably, trading volume dropped by 863.2K shares on the last day despite the price increase, which may signal a potential uptick in risk in the near term. A total of 4.0M shares were traded, equating to a market value of approximately $3.0B.
01875.HK 기술적 시그널
기술적 시그널 요약
구매 신호 3
중립 신호 2
매도 신호 2
Strong Sell
Sell
Neutral
Buy
Strong Buy
01875.HK은 현재 3개의 매수 신호와 2개의 매도 신호를 보이고 있습니다. 이 주식은 12:00 AM 이후로 상승 추세 상태에 있으며, 이 기간 동안 총 가격 변동률은 --입니다. 전반적으로 기술적 지표들은 중기적으로 Buy 전망을 나타내고 있습니다.
01875.HK에 대한 강세/약세 신호
이동평균, RSI, MACD, 거래량 등 핵심 지표를 분석하여 01875.HK 의 강세/약세 시그널을 생성합니다. 이 인사이트를 활용해 더 현명한 투자 결정을 내리세요.